
-
Genmab NASDAQ:GMAB Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.
Location: Koebenhavn V, 1560, Denmark | Website: http://www.genmab.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-18.9B
Cash
21.1B
Avg Qtr Burn
N/A
Short % of Float
4.88%
Insider Ownership
0.01%
Institutional Own.
9.30%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Epkinly (epcoritamab) Details Follicular lymphoma, Cancer | Approved Quarterly sales |